Lexicon Pharma (LXRX) Tops Q2 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) | Delayed: 1.44 +0.02 (1.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.42 | 52 Week High | $19.62 | |||
| Open | $1.44 | 52 Week Low | $7.65 | |||
| Day High | $1.45 | P/E | N/A | |||
| Day Low | $1.40 | EPS | $-0.22 | |||
| Volume | 2,020,751 | |||||
